Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism

Deborah Y. Park, BS, Shyam K. Poudel, MD, Xuefei Jia, MS, Mailey Lynn Wilks, CNP, MSN, APRN, Vicki Pinkava, MSBS, PA-C, Meghan O'Brien, MS, ANP-BC, Barbara Tripp, CNS,AOCN, Jung-Min Song, RN,CNS, Keith R. McCrae, MD, Dana E. Angelini, MD, Alok A. Khorana, MD

Blood (2018) 132 (Supplement 1): 1237.

https://doi.org/10.1182/blood-2018-99-111897

Published: 2018

Journal Articles

Late Effects of CD19-Targeted CAR-T Cell Therapy

Ana Cordeiro, Evandro D Bezerra, Joshua Aiden Hill, MD, Cameron J. Turtle, MBBS, PhD, David G. Maloney, MD PhD, Merav Bar, MD

Blood (2018) 132 (Supplement 1): 223.

https://doi.org/10.1182/blood-2018-99-112023

Published: 2018

Journal Articles

A Phase 1 Study Investigating the Combination of AFM13 and the Monoclonal Anti-PD-1 Antibody Pembrolizumab in Patients with Relapsed/Refractory Hodgkin Lymphoma after Brentuximab Vedotin Failure: Data from the Dose Escalation Part of the Study

Stephen M Ansell, MD PhD, Robert W. Chen, MD, Andres Forero-Torres, MD, Philippe Armand, MD PhD, Izidore S Lossos, MD, Craig B. Reeder, MD, Andras Strassz, MD, Anne Kerber, MD, Nancy L. Bartlett, MD

Blood (2017) 130 (Supplement 1): 1522.

https://doi.org/10.1182/blood.V130.Suppl_1.1522.1522

Published: 2017

Journal Articles

HARMONY: An Open-Label, Multicenter, 2-Arm, Dose-Finding, Phase 1b Study of the Combination of Ruxolitinib and Buparlisib (BKM120) in Patients with Myelofibrosis (MF)

Simon Durrant, MD, Maya Koren-Michowitz, MD, David Lavie, Joaquin Martinez-Lopez, MD PhD, Alessandro M. Vannucchi, MD, Francesco Passamonti, MD, Viktoriya Stalbovskaya, PhD, Edric Atienza, MSHS, Dana Iommazzo, Prashanth Gopalakrishna, MBBS, MRCS, Heinz Gisslinger, MD

Blood (2014) 124 (21): 710.

https://doi.org/10.1182/blood.V124.21.710.710

Published: 2014

Journal Articles

Intra-Arterial Catheter Guided Steroid Administration For The Treatment Of Steroid-Refractory Intestinal GvHD

Michael Medinger, MD, David Buergler, MD, Jakob Passweg, MD, Arne Fischmann, MD, Christoph Bucher, MD

Blood (2013) 122 (21): 4604.

https://doi.org/10.1182/blood.V122.21.4604.4604

Published: 2013

Journal Articles

Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin For Patients With Relapsed/Refractory Multiple Myeloma: Results From a Phase 1/2 Trial

James R. Berenson, MD, James D. Hilger, Ph.D., Leonard Klein, MD, Alberto Bessudo, MD, Peter J. Rosen, MD, Shahrooz Eshaghian, MD, Youram Nassir, MD, Regina A. Swift, RN, Robert Vescio, MD

Blood (2013) 122 (21): 3218.

https://doi.org/10.1182/blood.V122.21.3218.3218

Published: 2013

Journal Articles

APOBEC3G enhances lymphoma cell radioresistance by promoting cytidine deaminase-dependent DNA repair

Roni Nowarski, Ofer I. Wilner, Ori Cheshin, Or D. Shahar, Edan Kenig, Leah Baraz, Elena Britan-Rosich, Arnon Nagler, Reuben S. Harris, Michal Goldberg, Itamar Willner, Moshe Kotler

Blood (2012) 120 (2): 366–375.

https://doi.org/10.1182/blood-2012-01-402123

Published: 2012

Includes: Supplemental data

Journal Articles

The mismatch repair pathway functions normally at a non-AID target in germinal center B cells

Blerta Green, Antoaneta Belcheva, Rajeev M. Nepal, Bryant Boulianne, Alberto Martin

Blood (2011) 118 (11): 3013–3018.

https://doi.org/10.1182/blood-2011-03-345991

Published: 2011

Includes: Supplemental data

Journal Articles

A Prospective Evaluation of Adult Men with Iron Deficiency Anemia

Hyo Jin Lee, Ik Chan Song, Gak Won Yun, Hwan Jung Yun, Samyong Kim, Deog Yeon Jo

Blood (2010) 116 (21): 2054.

https://doi.org/10.1182/blood.V116.21.2054.2054

Published: 2010

Journal Articles

A Clinical Significance of Helicobacter Pylori Infection in Hemophilic Children with Gastrointestinal Hemorrhage.

Ji Yoon Kim, MD, Yong-Mook Choi, MD, Kun Soo Lee, M.D.

Blood (2009) 114 (22): 4442.

https://doi.org/10.1182/blood.V114.22.4442.4442

Published: 2009

Journal Articles

Comparative Pharmacokinetic/Pharmacodynamic Profiles in Japanese and Caucasian Patients with Transfusional Hemosiderosis Receiving Treatment with Deferasirox (Exjade®, ICL670).

S. Iki, A. Urabe, T. Hata, K. Ohyashiki, S. Nakao, M. Takatoku, T. Ishikawa, J. Kato, Y. Tatsumi, H. Mori, H. Tanii, J. Taniguchi, M. Kondo, H. Schran, B. Rabault

Blood (2006) 108 (11): 4845.

https://doi.org/10.1182/blood.V108.11.4845.4845

Published: 2006

Journal Articles

The Combined Use of Hydroxyurea and Anagrelide Allows Better Hematologic Control in Patients with Chronic Myeloproliferative Disorders and Thrombocytosis. A Report on 13 Patients with Poor Tolerance to Hydroxyurea Monotherapy.

Moira Micheletti, MD, Mariella D’Adda, MD, Monica Drera, MD, Samantha Ferrari, MSt, Giuseppe Rossi, MD

Blood (2006) 108 (11): 4892.

https://doi.org/10.1182/blood.V108.11.4892.4892

Published: 2006

Journal Articles

Correlation between Helicobacter Pylori Eradication and Platelet Count in Immune Thrombocytopenic Purpura (ITP).

Jun Ho Jang, MD, Hyeoung Il Kim, MD, Hyun Woo Lee, MD, Seok Yun Kang, MD, Joon Seong Park, MD, Jin Hyuk Choi, MD, Ho Yeong Lim, MD, Hugh C. Kim, MD

Blood (2005) 106 (11): 4003.

https://doi.org/10.1182/blood.V106.11.4003.4003

Published: 2005

Journal Articles

Influence of Perceived Risk Factors for Bleeding on Venous Thromboembolism Prophylaxis Practices in Acutely Ill Medical Patients: Findings from IMPROVE.

Manuel Monreal, MD, Rainer B. Zotz, MD, Hervé Decousus, MD, Beng H. Chong, MD, PhD, Geno Merli, MD, Ricardo Pavanello, MD, Mario Pini, MD, Alexander G.G. Turpie, MD, Wei Huang, Frederick A. Anderson, Jr., PhD, for the IMPROVE Investigators

Blood (2005) 106 (11): 917.

https://doi.org/10.1182/blood.V106.11.917.917

Published: 2005

Journal Articles

Yttrium-90 Ibritumomab Tiuxetan (Zevalin) for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Not Appropriate for Autologous Stem Cell Transplantation: Results of an Open-Label Phase II Trial.

F. Morschhauser, D. Huglo, G. Martinelli, G. Paganelli, P.L. Zinzani, D. Hadjiyiannakis, A. Liberati, T. Illidge, N. Milpied, H. Stein, J. Kalmus, P. Morel, U. Reimann, R. Marcus

Blood (2004) 104 (11): 130.

https://doi.org/10.1182/blood.V104.11.130.130

Published: 2004

NARROW

Clinical Outcomes with Direct Oral Anticoagulants Compared to Low Molecular Weight Heparins in the Treatment of Cancer-Associated Venous Thromboembolism

Late Effects of CD19-Targeted CAR-T Cell Therapy

A Phase 1 Study Investigating the Combination of AFM13 and the Monoclonal Anti-PD-1 Antibody Pembrolizumab in Patients with Relapsed/Refractory Hodgkin Lymphoma after Brentuximab Vedotin Failure: Data from the Dose Escalation Part of the Study

HARMONY: An Open-Label, Multicenter, 2-Arm, Dose-Finding, Phase 1b Study of the Combination of Ruxolitinib and Buparlisib (BKM120) in Patients with Myelofibrosis (MF)

Intra-Arterial Catheter Guided Steroid Administration For The Treatment Of Steroid-Refractory Intestinal GvHD

Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin For Patients With Relapsed/Refractory Multiple Myeloma: Results From a Phase 1/2 Trial

APOBEC3G enhances lymphoma cell radioresistance by promoting cytidine deaminase-dependent DNA repair

The mismatch repair pathway functions normally at a non-AID target in germinal center B cells

A Prospective Evaluation of Adult Men with Iron Deficiency Anemia

A Clinical Significance of Helicobacter Pylori Infection in Hemophilic Children with Gastrointestinal Hemorrhage.

Comparative Pharmacokinetic/Pharmacodynamic Profiles in Japanese and Caucasian Patients with Transfusional Hemosiderosis Receiving Treatment with Deferasirox (Exjade®, ICL670).

The Combined Use of Hydroxyurea and Anagrelide Allows Better Hematologic Control in Patients with Chronic Myeloproliferative Disorders and Thrombocytosis. A Report on 13 Patients with Poor Tolerance to Hydroxyurea Monotherapy.

Correlation between Helicobacter Pylori Eradication and Platelet Count in Immune Thrombocytopenic Purpura (ITP).

Influence of Perceived Risk Factors for Bleeding on Venous Thromboembolism Prophylaxis Practices in Acutely Ill Medical Patients: Findings from IMPROVE.

Yttrium-90 Ibritumomab Tiuxetan (Zevalin) for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Not Appropriate for Autologous Stem Cell Transplantation: Results of an Open-Label Phase II Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only